Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
Go back to Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.85 -0.15 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $44.38 | |||
| Open | $8.14 | 52 Week Low | $24.47 | |||
| Day High | $8.26 | P/E | 392.50 | |||
| Day Low | $7.83 | EPS | $0.02 | |||
| Volume | 1,558,073 | |||||
